Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy

por Loi, Sherene
Publicado 2013

Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Where Are We Now and Where Are We Headed?

por Dixon-Douglas, Julia, Loi, Sherene
Publicado 2023

Triple-negative breast cancer: recent treatment advances

por Bergin, Alice R T, Loi, Sherene
Publicado 2019

Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 update()

por Brown, Lauren C., Loi, Sherene
Publicado 2021

PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data

por Zardavas, Dimitrios, Phillips, Wayne A, Loi, Sherene
Publicado 2014

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy

por Luen, Stephen L., Salgado, Roberto, Loi, Sherene
Publicado 2019

Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection

por Criscitiello, Carmen, Fumagalli, Debora, Saini, Kamal S, Loi, Sherene
Publicado 2010

Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context

por Abraham, Gad, Kowalczyk, Adam, Loi, Sherene, Haviv, Izhak, Zobel, Justin
Publicado 2010

Checkpoint blockade in the treatment of breast cancer: current status and future directions

por Wein, Lironne, Luen, Stephen J, Savas, Peter, Salgado, Roberto, Loi, Sherene
Publicado 2018

Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions

por David, Steven, Tan, Jennifer, Siva, Shankar, Karroum, Lama, Savas, Peter, Loi, Sherene
Publicado 2022

Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions

por Wein, Lironne, Savas, Peter, Luen, Stephen J., Virassamy, Balaji, Salgado, Roberto, Loi, Sherene
Publicado 2017

Feasibility of developing reliable gene expression modules from FFPE derived RNA profiled on Affymetrix arrays

por Jose, Vinu, Fumagalli, Debora, Rothé, Françoise, Majjaj, Samira, Loi, Sherene, Michiels, Stefan, Sotiriou, Christos
Publicado 2018

Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer

por Rohan, Thomas E., Arthur, Rhonda, Wang, Yihong, Weinmann, Sheila, Ginsberg, Mindy, Loi, Sherene, Salgado, Roberto
Publicado 2021

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial

por David, Steven, Tan, Jennifer, Savas, Peter, Bressel, Mathias, Kelly, Dianne, Foroudi, Farshad, Loi, Sherene, Siva, Shankar
Publicado 2019

Relevance of tumor-infiltrating lymphocytes in breast cancer

por Dushyanthen, Sathana, Beavis, Paul A., Savas, Peter, Teo, Zhi Ling, Zhou, Chenhao, Mansour, Mariam, Darcy, Phillip K., Loi, Sherene
Publicado 2015

Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses

por Oliver, Amanda J., Lau, Peter K. H., Unsworth, Ashleigh S., Loi, Sherene, Darcy, Phillip K., Kershaw, Michael H., Slaney, Clare Y.
Publicado 2018

Understanding the barriers to, and facilitators of, ovarian toxicity assessment in breast cancer clinical trials

por Cui, Wanyuan, Phillips, Kelly-Anne, Francis, Prudence A., Anderson, Richard A., Partridge, Ann H., Loi, Sherene, Loibl, Sibylle, Keogh, Louise
Publicado 2022

Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer

por Loi, Sherene, Sotiriou, Christos, Haibe-Kains, Benjamin, Lallemand, Francoise, Conus, Nelly M, Piccart, Martine J, Speed, Terence P, McArthur, Grant A
Publicado 2009

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy

por Azim, Hatem A, Peccatori, Fedro A, Brohée, Sylvain, Branstetter, Daniel, Loi, Sherene, Viale, Giuseppe, Piccart, Martine, Dougall, William C, Pruneri, Giancarlo, Sotiriou, Christos
Publicado 2015

Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol

por Foulkes, Stephen J., Howden, Erin J., Antill, Yoland, Loi, Sherene, Salim, Agus, Haykowsky, Mark J., Daly, Robin M., Fraser, Steve F., La Gerche, Andre
Publicado 2020